Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Revenue came in at $97323.0 in Q3 2021, down 92.09% year-on-year from $1.2 million in Q3 2020, and down 28.73% quarter-over-quarter from $136558.0 in Q2 2021.
Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' Revenue history runs 7 years deep, the most recent figure standing at $97323.0 for Q3 2021.
- On a quarterly basis, Revenue fell 92.09% year-over-year to $97323.0 in Q3 2021; TTM through Jun 2022 was $97323.0, a 97.39% decrease from a year earlier, with the FY2021 full-year figure at $881705.0, down 82.37% from the prior year.
- Revenue declined to $97323.0 in Q3 2021 per CRBP's latest filing, from $136558.0 in the prior quarter.
- Across five years, Revenue topped out at $29.1 million in Q2 2019 and bottomed at -$28.6 million in Q4 2019.
- The 5-year median for Revenue is $902044.0 (2018), against an average of $912103.7.
- Biggest YoY gain for Revenue was 3308.27% in 2019; the steepest drop was 14313.95% in 2019.
- Year by year, Revenue stood at $796312.0 in 2017, then tumbled by 74.76% to $201000.0 in 2018, then sank by 14313.95% to -$28.6 million in 2019, then jumped by 106.02% to $1.7 million in 2020, then slumped by 94.34% to $97323.0 in 2021.
- Per Business Quant, the three latest CRBP Revenue figures stand at $97323.0 (Q3 2021), $136558.0 (Q2 2021), and $647824.0 (Q1 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 97,323.00 |
| Jun 30, 2021 | 136,558.00 |
| Mar 31, 2021 | 647,824.00 |
| Dec 31, 2020 | 1.72 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | 286,346.00 |
| Mar 31, 2020 | 1.76 Mn |
| Dec 31, 2019 | -28.57 Mn |
| Sep 30, 2019 | 2.59 Mn |
| Jun 30, 2019 | 29.09 Mn |
| Mar 31, 2019 | 1.89 Mn |
| Dec 31, 2018 | 201,000.00 |
| Sep 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 853,646.00 |
| Mar 31, 2018 | 950,442.00 |
| Sep 30, 2017 | 796,312.00 |
| Jun 30, 2017 | 350,186.00 |
| Mar 31, 2017 | 1.29 Mn |
| Sep 30, 2016 | 742,558.00 |
| Jun 30, 2016 | 396,598.00 |